You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mutation

Showing 1 - 25 of 7,034
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

Not yet recruiting
  • C-KIT Mutation
    • (no location specified)
    Nov 2, 2023

    AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

    Not yet recruiting
    • AXIN1 Gene Mutation
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

    Not yet recruiting
    • Aumolertinib
    • +4 more
    • (no location specified)
    Mar 8, 2023

    C677T Methylenetetrahydrofolate Reductase Mutation

    Completed
    • Mutation
    • infertily evaluation
    • (no location specified)
    May 16, 2023

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2023

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

    Not yet recruiting
    • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
    • Non-investigational
    • (no location specified)
    May 11, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Gene Mutation Trial in Beijing (RAG-17)

    Enrolling by invitation
    • Gene Mutation
    • Beijing, China
      Beijing Tiantan Hospital
    Jun 11, 2023

    Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Peking, China
      Peking Union Medical College Hospital
    Nov 16, 2023

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

    Recruiting
    • Biallelic RPE65 Mutation-associated Retinal Dystrophy
    • FT-001 Low Dose
    • +2 more
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 11, 2023

    Homologous Recombination Repair Pathway Gene Mutation Spectrum

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jun 4, 2023

      Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

      Recruiting
      • Her-2 Negative Breast Cancer
      • HRR Gene Mutation
      • Guangzhou, Guangdong, China
        First Affiliated Hospital, Sun Yat-Sen University
      Mar 7, 2023

      Predictive Cancer Model Trial in Prague (colonoscopy)

      Recruiting
      • Predictive Cancer Model
      • colonoscopy
      • Prague, Czechia
        Military University Hospital
      Jun 25, 2023

      Each Codon-specific KRAS Mutation in Colorectal Cancer

      Completed
      • Colorectal Cancer
      • Mutation
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        Seoul National University Bundang Hospital
      Dec 10, 2022

      ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

      Recruiting
      • ARID1A Gene Mutation
      • +15 more
      • Scottsdale, Arizona
      • +4 more
      Dec 13, 2022

      GIST Trial in Xi'an (Imatinib)

      Recruiting
      • GIST
      • Xi'an, Shaanxi, China
        Xijing Hospital of Air Force Military Medical University
      Jun 8, 2023

      Central Nervous System Metastatic EGFR Mutation Positive NSCLC

      Not yet recruiting
      • NSCLC
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Aug 6, 2023

        Lung Cancer Mutation Consortium Protocol

        Active, not recruiting
        • Adenocarcinoma of Lung, Stage IV
          • Aurora, Colorado
            University of Colorado Denver Cancer Center
          Jan 30, 2023

          Fabry Disease Trial in Taipei

          Recruiting
          • Fabry Disease
            • Taipei, Taiwan
              Investigational Site Number :1580001
            Sep 24, 2023

            Patterns Among PIK3CA Mutation in Advanced Breast Cancer

            Completed
            • Breast Cancer
              • East Hanover, New Jersey
                Novartis
              Aug 1, 2023